Details for Patent: 8,771,733
Which drugs does patent 8,771,733 protect, and when does it expire?
Patent 8,771,733 protects ISENTRESS and ISENTRESS HD and is included in two NDAs.
This patent has eleven patent family members in eight countries.
Summary for Patent: 8,771,733
| Title: | Pharmaceutical composition containing an anti-nucleating agent |
| Abstract: | Pharmaceutical compositions suitable for oral administration in solid dosage forms are described. The compositions comprise an effective amount of a drug compound in the form of a salt, wherein the drug salt is characterized by conversion to a less soluble form of the drug compound under certain pH conditions, and an anti-nucleating agent. |
| Inventor(s): | Maria T. Cruanes, Wei Xu, Laura M. Artino, Honggang Zhu |
| Assignee: | Merck Sharp and Dohme LLC |
| Application Number: | US11/792,190 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,771,733 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Process; Dosage form; |
Drugs Protected by US Patent 8,771,733
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Msd Sub Merck | ISENTRESS | raltegravir potassium | TABLET, CHEWABLE;ORAL | 203045-002 | Dec 21, 2011 | RX | Yes | Yes | 8,771,733 | ⤷ Start Trial | Y | Y | TREATMENT OF HIV INFECTION | ⤷ Start Trial | ||
| Msd Sub Merck | ISENTRESS | raltegravir potassium | TABLET;ORAL | 022145-001 | Oct 12, 2007 | AB | RX | Yes | Yes | 8,771,733 | ⤷ Start Trial | Y | Y | TREATMENT OF HIV INFECTION | ⤷ Start Trial | |
| Msd Sub Merck | ISENTRESS HD | raltegravir potassium | TABLET;ORAL | 022145-002 | May 26, 2017 | AB | RX | Yes | Yes | 8,771,733 | ⤷ Start Trial | Y | Y | TREATMENT OF HIV INFECTION | ⤷ Start Trial | |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,771,733
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2005311714 | ⤷ Start Trial | |||
| Canada | 2588465 | ⤷ Start Trial | |||
| China | 101068533 | ⤷ Start Trial | |||
| European Patent Office | 1819323 | ⤷ Start Trial | |||
| European Patent Office | 3165220 | ⤷ Start Trial | |||
| Spain | 2727577 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
